News
Health Matters: Health Canada approves Ozempic to help reduce kidney decline
Health Canada has approved Ozempic in an effort to help reduce the risk of kidney decline for patients living with Type 2 diabetes. The decision comes after an international clinical trial found the risk of deteriorating kidney function was 24 per cent lower in patients taking Ozempic compared to those taking a placebo injection.
With Halloween shops opening and pumpkin spice in the air, it’s also time to think about getting a new COVID-19 vaccine for ...
Apotex Inc. ("Apotex" or the "Company"), the Canadian-based global health company, today announced that Health Canada has approved Aflivu™ (aflibercept), a biosimilar to Eylea®, indicated for ...
Canada will put warning labels on individual cigarettes. Health Canada Health Canada said the strategy aims to reduce tobacco use below 5% by 2035.
TipRanks on MSN16h
Iovance Biotherapeutics Gains Health Canada Approval
Iovance Biotherapeutics ( ($IOVA) ) has shared an update. On August 18, 2025, Iovance Biotherapeutics announced that its product Amtagvi® ...
The Liberals released their platform on April 19, and when it comes to health care in Canada, one of the party's major goals is to boost access to primary care. That includes spending $4 billion ...
Health officials warn residents in Nova Scotia, Ontario, and Quebec about a potential Listeria monocytogenes contamination ...
The joint recall includes Health Canada, the United States Consumer Product Safety Commission and i-Drink Products Inc.
Stocktwits on MSN22h
Iovance Stock Rises 4% On Health Canada Approval For Cancer Immunotherapy: Retail Thinks ‘Patience Will Pay Off’
Shares of Iovance Biotherapeutics Inc. (IOVA) traded 4% higher on Tuesday morning after Health Canada approved the company’s immunotherapy for the treatment of advanced melanoma. On Stocktwits, retail ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback